Cargando…
CIP2A Influences Survival in Colon Cancer and Is Critical for Maintaining Myc Expression
The cancerous inhibitor of protein phosphatase 2A (CIP2A) is an oncogenic factor that stabilises the c-Myc protein. CIP2A is overexpressed in several tumours, and expression levels are an independent marker for long-term outcome. To determine whether CIP2A expression is elevated in colon cancer and...
Autores principales: | Wiegering, Armin, Pfann, Christina, Uthe, Friedrich Wilhelm, Otto, Christoph, Rycak, Lukas, Mäder, Uwe, Gasser, Martin, Waaga-Gasser, Anna-Maria, Eilers, Martin, Germer, Christoph-Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788051/ https://www.ncbi.nlm.nih.gov/pubmed/24098375 http://dx.doi.org/10.1371/journal.pone.0075292 |
Ejemplares similares
-
The intraportal injection model: A practical animal model for hepatic metastases and tumor cell dissemination in human colon cancer
por: Thalheimer, Andreas, et al.
Publicado: (2009) -
CIP2A regulates MYC translation (via its 5′UTR) in colorectal cancer
por: Denk, S., et al.
Publicado: (2020) -
The role of FOXP3 in disease progression in colorectal cancer patients
por: Grimmig, Tanja, et al.
Publicado: (2013) -
A MYC/GCN2/eIF2α negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer
por: Schmidt, Stefanie, et al.
Publicado: (2019) -
Evaluation of immunological escape mechanisms in a mouse model of colorectal liver metastases
por: Grimm, Martin, et al.
Publicado: (2010)